Binding of the rhesus TRIM5α PRYSPRY domain to capsid is necessary but not sufficient for HIV-1 restriction

Virology

Volumn 448, Issue , 2014, Pages 217-228

  Yang, Yang ^a   Brandariz Nuñez, Alberto ^a   Fricke, Thomas ^a   Ivanov, Dmitri N ^b   Sarnak, Zoe ^a   Diaz Griffero, Felipe ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Capsid; HIV 1; PRYSPRY; Restriction; TRIM5; V1 loop

Indexed keywords

MEMBRANE PROTEIN; TRIPARTITE MOTIF PROTEIN 34; TRIPARTITE MOTIF PROTEIN 5; TRIPARTITE MOTIF PROTEIN 6; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN STRUCTURE; RHESUS MONKEY; STRUCTURE ACTIVITY RELATION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS CORE; VIRUS INHIBITION; WILD TYPE;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 84887014090     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.10.012     Document Type: Article

References (56)

1. Best S., Le Tissier P., Towers G., Stoye J.P. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 1996, 382:826-829.
2. Biris N., Yang Y., Taylor A.B., Tomashevski A., Guo M., Hart P.J., Diaz-Griffero F., Ivanov D.N. Structure of the rhesus monkey TRIM5alpha PRYSPRY domain, the HIV capsid recognition module. Proc. Natl. Acad. Sci. U S A 2012, 109:13278-13283.
3. Brandariz-Nunez A., Roa A., Valle-Casuso J.C., Biris N., Ivanov D., Diaz-Griffero F. Contribution of SUMO-interacting motifs and SUMOylation to the antiretroviral properties of TRIM5alpha. Virology 2013, 435:463-471.
4. Day R.N., Davidson M.W. Fluorescent proteins for FRET microscopy: monitoring protein interactions in living cells. Bioessays 2012, 34:341-350.
5. Diaz-Griffero F., Gallo D.E., Hope T.J., Sodroski J. Trafficking of some old world primate TRIM5alpha proteins through the nucleus. Retrovirology 2011, 8:38.
6. Diaz-Griffero F., Kar A., Lee M., Stremlau M., Poeschla E., Sodroski J. Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp. Virology 2007, 369(2):400-410.
7. Diaz-Griffero F., Kar A., Perron M., Xiang S.H., Javanbakht H., Li X., Sodroski J. Modulation of retroviral restriction and proteasome inhibitor-resistant turnover by changes in the TRIM5alpha B-box 2 domain. J. Virol. 2007, 81:10362-10378.
8. Diaz-Griffero F., Li X., Javanbakht H., Song B., Welikala S., Stremlau M., Sodroski J. Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology 2006, 349:300-315.
9. Diaz-Griffero F., Perron M., McGee-Estrada K., Hanna R., Maillard P.V., Trono D., Sodroski J. A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus. Virology 2008, 378:233-242.
10. Diaz-Griffero F., Qin X.R., Hayashi F., Kigawa T., Finzi A., Sarnak Z., Lienlaf M., Yokoyama S., Sodroski J. A B-box 2 surface patch important for TRIM5alpha self-association, capsid binding avidity, and retrovirus restriction. J. Virol. 2009, 83:10737-10751.
11. Diaz-Griffero F., Vandegraaff N., Li Y., McGee-Estrada K., Stremlau M., Welikala S., Si Z., Engelman A., Sodroski J. Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1. Virology 2006, 351:404-419.
12. Fornerod M., Ohno M., Yoshida M., Mattaj I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 1997, 90:1051-1060.
13. Ganser B.K., Li S., Klishko V.Y., Finch J.T., Sundquist W.I. Assembly and analysis of conical models for the HIV-1 core. Science 1999, 283:80-83.
14. Ganser-Pornillos B.K., Chandrasekaran V., Pornillos O., Sodroski J.G., Sundquist W.I., Yeager M. Hexagonal assembly of a restricting TRIM5alpha protein. Proc. Natl. Acad. Sci. USA 2011, 108:534-539.
15. Ganser-Pornillos B.K., von Schwedler U.K., Stray K.M., Aiken C., Sundquist W.I. Assembly properties of the human immunodeficiency virus type 1 CA protein. J. Virol. 2004, 78:2545-2552.
16. Ganser-Pornillos B.K., Yeager M., Sundquist W.I. The structural biology of HIV assembly. Curr. Opin. Struct. Biol. 2008, 18:203-217.
17. Javanbakht H., Diaz-Griffero F., Stremlau M., Si Z., Sodroski J. The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha. J. Biol. Chem. 2005, 280:26933-26940.
18. Kar A.K., Diaz-Griffero F., Li Y., Li X., Sodroski J. Biochemical and biophysical characterization of a chimeric TRIM21-TRIM5alpha protein. J. Virol. 2008, 82:11669-11681.
19. Keckesova Z., Ylinen L.M., Towers G.J. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc. Natl. Acad. Sci. USA 2004, 101:10780-10785.
20. Kim J., Tipper C., Sodroski J. Role of TRIM5{alpha} RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus. J. Virol. 2011, 85:8116-8132.
21. Kirmaier A., Wu F., Newman R.M., Hall L.R., Morgan J.S., O'Connor S., Marx P.A., Meythaler M., Goldstein S., Buckler-White A., Kaur A., Hirsch V.M., Johnson W.E. TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol. 2010, 8(8).
22. Kono K., Song H., Yokoyama M., Sato H., Shioda T., Nakayama E.E. Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5alpha-mediated restriction. Retrovirology 2010, 7:72.
23. Kudo N., Wolff B., Sekimoto T., Schreiner E.P., Yoneda Y., Yanagida M., Horinouchi S., Yoshida M. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 1998, 242:540-547.
24. Kuersten S., Ohno M., Mattaj I.W. Nucleocytoplasmic transport: Ran, beta and beyond. Trends Cell Biol. 2001, 11:497-503.
25. Langelier C.R., Sandrin V., Eckert D.M., Christensen D.E., Chandrasekaran V., Alam S.L., Aiken C., Olsen J.C., Kar A.K., Sodroski J.G., Sundquist W.I. Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication. J. Virol. 2008, 82:11682-11694.
26. Li X., Gold B., O'HUigin C., Diaz-Griffero F., Song B., Si Z., Li Y., Yuan W., Stremlau M., Mische C., Javanbakht H., Scally M., Winkler C., Dean M., Sodroski J. Unique features of TRIM5alpha among closely related human TRIM family members. Virology 2007, 360:419-433.
27. Li X., Kim J., Song B., Finzi A., Pacheco B., Sodroski J. Virus-specific effects of TRIM5alpha(rh) RING domain functions on restriction of retroviruses. J. Virol. 2013, 87:7234-7245.
28. Li Y., Li X., Stremlau M., Lee M., Sodroski J. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection. J. Virol. 2006, 80:6738-6744.
29. Lienlaf M., Hayashi F., Di Nunzio F., Tochio N., Kigawa T., Yokoyama S., Diaz-Griffero F. Contribution of E3-ubiquitin ligase activity to HIV-1 restriction by TRIM5alpha(rh): structure of the RING domain of TRIM5alpha. J. Virol. 2011, 85:8725-8737.
30. Lukic Z., Goff S.P., Campbell E.M., Arriagada G. Role of SUMO-1 and SUMO interacting motifs in rhesus TRIM5alpha-mediated restriction. Retrovirology 2013, 10:10.
31. Maegawa H., Miyamoto T., Sakuragi J., Shioda T., Nakayama E.E. Contribution of RING domain to retrovirus restriction by TRIM5alpha depends on combination of host and virus. Virology 2010, 399:212-220.
32. Mohr D., Frey S., Fischer T., Guttler T., Gorlich D. Characterisation of the passive permeability barrier of nuclear pore complexes. EMBO J. 2009, 28:2541-2553.
33. Mrosek M., Meier S., Ucurum-Fotiadis Z., von Castelmur E., Hedbom E., Lustig A., Grzesiek S., Labeit D., Labeit S., Mayans O. Structural analysis of B-Box 2 from MuRF1: identification of a novel self-association pattern in a RING-like fold. Biochemistry 2008, 47:10722-10730.
34. Nakayama E.E., Miyoshi H., Nagai Y., Shioda T. A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection. J. Virol. 2005, 79:8870-8877.
35. Ohkura S., Goldstone D.C., Yap M.W., Holden-Dye K., Taylor I.A., Stoye J.P. Novel escape mutants suggest an extensive TRIM5alpha binding site spanning the entire outer surface of the murine leukemia virus capsid protein. PLoS Pathog. 2011, 7:e1002011.
36. Ohkura S., Stoye J.P. A comparison of murine leukemia viruses that escape from human and rhesus macaque TRIM5alphas. J. Virol. 2013, 87:6455-6468.
37. Ohkura S., Yap M.W., Sheldon T., Stoye J.P. All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction. J. Virol. 2006, 80:8554-8565.
38. Owens C.M., Yang P.C., Gottlinger H., Sodroski J. Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells. J. Virol. 2003, 77:726-731.
39. Padilla-Parra S., Tramier M. FRET microscopy in the living cell: different approaches, strengths and weaknesses. Bioessays 2012, 34:369-376.
40. Perez-Caballero D., Hatziioannou T., Yang A., Cowan S., Bieniasz P.D. Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity. J. Virol. 2005, 79:8969-8978.
41. Perron M.J., Stremlau M., Lee M., Javanbakht H., Song B., Sodroski J. The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid. J. Virol. 2007, 81:2138-2148.
42. Pertel T., Hausmann S., Morger D., Zuger S., Guerra J., Lascano J., Reinhard C., Santoni F.A., Uchil P.D., Chatel L., Bisiaux A., Albert M.L., Strambio-De-Castillia C., Mothes W., Pizzato M., Grutter M.G., Luban J. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011, 472:361-365.
43. Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S., Pelicci P.G., Ballabio A. The tripartite motif family identifies cell compartments. EMBO J. 2001, 20:2140-2151.
44. Sawyer S.L., Wu L.I., Emerman M., Malik H.S. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc. Natl. Acad. Sci. USA 2005, 102:2832-2837.
45. Sayah D.M., Sokolskaja E., Berthoux L., Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004, 430:569-573.
46. Sebastian S., Grutter C., Strambio de Castillia C., Pertel T., Olivari S., Grutter M.G., Luban J. An invariant surface patch on the TRIM5alpha PRYSPRY domain is required for retroviral restriction but dispensable for capsid binding. J. Virol. 2009, 83:3365-3373.
47. Sebastian S., Luban J. TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2005, 2:40.
48. Song B., Gold B., O'Huigin C., Javanbakht H., Li X., Stremlau M., Winkler C., Dean M., Sodroski J. The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates. J. Virol. 2005, 79:6111-6121.
49. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
50. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., Diaz-Griffero F., Anderson D.J., Sundquist W.I., Sodroski J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. USA 2006, 103:5514-5519.
51. Stremlau M., Perron M., Welikala S., Sodroski J. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J. Virol. 2005, 79:3139-3145.
52. Watanabe M., Fukuda M., Yoshida M., Yanagida M., Nishida E. Involvement of CRM1, a nuclear export receptor, in mRNA export in mammalian cells and fission yeast. Genes Cells 1999, 4:291-297.
53. Wolff B., Sanglier J.J., Wang Y. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem. Biol. 1997, 4:139-147.
54. Yamauchi K., Wada K., Tanji K., Tanaka M., Kamitani T. Ubiquitination of E3 ubiquitin ligase TRIM5 alpha and its potential role. FEBS J. 2008, 275:1540-1555.
55. Yap M.W., Nisole S., Stoye J.P. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction. Curr. Biol. 2005, 15:73-78.
56. Zhang F., Hatziioannou T., Perez-Caballero D., Derse D., Bieniasz P.D. Antiretroviral potential of human tripartite motif-5 and related proteins. Virology 2006, 353:396-409.